BJ Scheessele

Chief Commercial Officer at Humacyte

Mr. Scheessele is a commercial leader with over 20 years of experience creating and growing businesses in the vascular and regenerative medicine markets. He is responsible for providing leadership, direction, and strategic vision to drive the commercial launch of the HAV in its initial vascular indications and follow-on market expansion.

Links

Timeline

  • Chief Commercial Officer

    August, 2021 - present